PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1164931
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1164931
Digital Biomanufacturing Market size was valued at USD 16,300.5 Million in 2021, expanding at a CAGR of 10.2% from 2022 to 2028.
Digital biomanufacturing enables the next generation of biomanufacturing processes through the adoption of Artificial intelligence, machine learning, and augmented reality, among other advanced technologies.
The increasing adoption of digital biomanufacturing at smart factories, and production facilities are boosting the digital biomanufacturing market growth. Further, Real-time production monitoring made possible by automated control systems can help smart factories become more sustainable by minimizing maintenance costs and the number of unsuccessful batches. Therefore, it is essential for biomanufacturing companies to be able to control bioprocesses autonomously and appropriately in their ideal state since this helps to reduce or maintain production costs, increase yields, and maintain product quality uniformity. The market will be stimulated by these benefits as companies are growingly utilizing digital solutions in biomanufacturing.
Growing environmental concerns, pollution levels, water scarcity, and seamless services in the pharmaceutical industry will propel the global biomanufacturing market. Digitalization in the form of Big Data and applications influenced by Digital Twins is a prominent topic in the biomanufacturing industry. As a result, plenty of businesses are devoting personnel and resources to these applications. A focused survey was conducted among people from the Danish biotech industry to assess the current state and anticipated future challenges in integrating digitalization principles in biotech production processes. Additionally, the usage of single-use products will reduce costs, decrease product contamination, and boost flexibility, increasing demand for next-generation biomanufacturing. COVID-19 has had a positive impact on the market as the growing technological awareness among manufacturing companies has boosted the growth of the digital biomanufacturing market.
The Global Digital Biomanufacturing Market is segmented on the basis of Technology, End User, and Region.
The market is split into five categories based on Technology: process analytical technologies, data analytics software, AI and IoT Solutions, predictive analytics and digital twin technologies, and others. The process analytical technologies segment dominates the market. Increasing adoption of analytics technologies in biomanufacturing is mainly contributing to segment growth.
The market is segmented into three categories based on End Users: pharmaceutical companies, research, and others. The pharmaceutical companies segment dominates the market and is likely to maintain its dominance during the forecast period. This is mainly owing to an increase in the demand for digitization in the pharma industry.
The global market for digital biomanufacturing is moderately fragmented with a few large market players dominating the market. The companies in the market stress adopting several strategies to develop new products and reach out larger consumer base across multiple countries. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, collaboration, distribution network development, R&D spending, and mergers and acquisitions.
For instance, in October 2022, Atos SE was selected by Indorama Ventures Public Company Limited, a world-sustainable chemical firm. It has implemented the company's first, cohesive digital operations that will bring together its Integrated Oxides and Derivatives (IOD) verticals across North America into a hybrid cloud environment.
This proposed research study on Digital Biomanufacturing market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2022-2028), considering 2021 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Digital Biomanufacturing market
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Digital Biomanufacturing market
Impact of COVID-19 on Digital Biomanufacturing market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Digital Biomanufacturing market post-COVID will also be covered.
In order to give the users of this report a comprehensive view on the Digital Biomanufacturing market, we have also included competitive landscape and key innovator analysis for the Digital Biomanufacturing market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Digital Biomanufacturing market.
In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
The global Digital Biomanufacturing market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
The scope of this report covers the market by its major segments, which include as follows:
Agilent Technologies
Atos SE
Danaher Corporation
Donaldson Company, Inc.
Emerson Electric Co.
General Electric Company
Honeywell International Inc.
SAP SE
Siemens Healthineers AG
Bota Biosciences
Culture Biosciences
Exponential Genomics, Inc.
FabricNano
OVO Biomanufacturing
GLOBAL DIGITAL BIOMANUFACTURING MARKET, BY TECHNOLOGY
Process analytical technologies
Data analytics software
AI and IoT solutions
Predictive analytics and digital twin technologies
Others
GLOBAL DIGITAL BIOMANUFACTURING MARKET, BY END USER
Pharmaceutical companies
Research
Others
GLOBAL DIGITAL BIOMANUFACTURING MARKET, BY REGION
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA